bf/NASDAQ:GH_icon.png

NASDAQ:GH

Guardant Health, Inc.

  • Stock

USD

Last Close

24.73

15/05 20:00

Market Cap

3.15B

Beta: 0.81

Volume Today

2.36M

Avg: 1.90M

PE Ratio

−5.81

PFCF: −7.12

Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
5.03M
-
8.21M
63.32%
12.16M
48.07%
18.95M
55.85%
26.70M
40.88%
41.14M
54.10%
56.77M
38.01%
average payables
4.08M
-
7.82M
91.78%
13.42M
71.60%
11.77M
12.30%
12.46M
5.88%
96.70M
676.07%
87.91M
9.09%
average receivables
8.14M
-
24.24M
197.73%
41.84M
72.61%
50.64M
21.04%
75.48M
49.04%
97.45M
29.12%
93.02M
4.55%
book value per share
1.13
-
4.36
287.23%
15.89
264.15%
8.81
44.55%
13.32
51.12%
6.37
52.19%
0.59
90.75%
1.42
140.58%
capex per share
-0.02
-
-0.13
408.66%
-0.66
423.11%
-0.23
64.64%
-0.55
135.99%
-0.74
33.58%
-0.76
2.36%
-0.18
75.87%
capex to depreciation
-0.48
-
-1.73
260.83%
-2.83
64.08%
-1.56
44.76%
-3.37
115.15%
-3.37
0.12%
-2.15
36.07%
-0.48
77.82%
capex to operating cash flow
0.05
-
0.12
158.50%
0.28
125.06%
0.45
61.35%
0.52
15.19%
0.36
30.99%
0.25
30.27%
0.06
74.82%
capex to revenue
-0.07
-
-0.18
157.68%
-0.22
23.67%
-0.10
55.46%
-0.19
89.89%
-0.20
6.51%
-0.17
14.19%
-0.04
78.92%
cash per share
1.35
-
3.13
132.34%
13.78
340.31%
5.77
58.12%
18.41
219.00%
9.21
49.99%
9.90
7.50%
10.44
5.44%
days of inventory on hand
45.68
-
84.12
84.14%
77.17
8.26%
78.35
1.53%
89.60
14.36%
91.09
1.66%
120.48
32.26%
271.12
125.04%
days payables outstanding
52.08
-
57.70
10.78%
89.89
55.80%
83.60
7.01%
28.95
65.37%
52.21
80.32%
410.51
686.34%
days sales outstanding
50.52
-
93.64
85.34%
143.72
53.48%
81.70
43.15%
67.85
16.96%
95.39
40.59%
78.97
17.22%
57.46
27.23%
debt to assets
0.15
-
0.00
98.69%
0.00
80.86%
0.04
11,313.12%
0.38
796.23%
0.62
65.67%
0.85
36.48%
0.74
12.74%
debt to equity
0.21
-
0.00
99.00%
0.00
79.06%
0.05
11,217.53%
0.66
1,200.60%
2.13
223.65%
22.75
968.32%
8.36
63.28%
dividend yield
0.00
-
0.00
-
earnings yield
-0.02
-
-0.04
80.37%
-0.07
103.65%
-0.01
87.12%
-0.02
104.48%
-0.04
93.74%
-0.24
520.29%
-0.16
32.80%
enterprise value
2.26B
-
2.21B
2.44%
1.00B
54.54%
6.97B
595.18%
12.58B
80.52%
11.00B
12.55%
4.01B
63.58%
3.22B
19.60%
enterprise value over ebitda
-57.34
-
-31.40
45.24%
-12.08
61.52%
-101.68
741.55%
-52.17
48.69%
-28.81
44.78%
-6.16
78.63%
-5.70
7.33%
ev to operating cash flow
-61.58
-
-30.53
50.42%
-13.89
54.51%
-147.86
964.65%
-121.06
18.13%
-52.64
56.52%
-12.95
75.40%
-9.91
23.44%
ev to sales
89.53
-
44.25
50.58%
11.06
75.00%
32.51
193.92%
43.88
34.97%
29.44
32.89%
8.91
69.73%
5.71
35.91%
free cash flow per share
-0.54
-
-1.15
111.09%
-3.04
164.58%
-0.76
75.15%
-1.62
114.55%
-2.80
73.03%
-3.79
35.06%
-3.08
18.54%
free cash flow yield
-0.02
-
-0.04
111.09%
-0.08
126.65%
-0.01
88.04%
-0.01
30.08%
-0.03
122.96%
-0.14
396.66%
-0.11
18.09%
graham net net
0.88
-
2.83
220.91%
12.76
350.56%
4.99
60.90%
9.54
91.25%
-5.31
155.69%
-4.30
18.96%
-3.23
25.00%
graham number
4.07
-
10.75
164.28%
31.63
194.24%
12.19
61.47%
27.51
125.76%
23.32
15.22%
9.21
60.50%
11.68
26.80%
income quality
0.80
-
0.87
9.09%
0.86
1.30%
0.69
18.91%
0.42
39.25%
0.54
28.73%
0.47
12.97%
0.68
43.37%
intangibles to total assets
0
-
0.03
Infinity%
0.01
47.89%
0.02
46.34%
0.01
55.85%
0.01
7.49%
0.01
17.52%
0.01
26.37%
interest coverage
-14.53
-
-28.35
95.16%
-74.29
162.03%
-69.75
6.12%
-53.49
23.30%
-159.49
198.14%
-211.24
32.45%
219.06
203.70%
interest debt per share
0.28
-
0.05
83.24%
0.05
1.52%
0.46
851.10%
8.81
1,820.26%
13.58
54.15%
13.43
1.17%
11.82
11.99%
inventory turnover
7.99
-
4.34
45.69%
4.73
9.00%
4.66
1.51%
4.07
12.56%
4.01
1.63%
3.03
24.39%
1.35
55.56%
invested capital
0.21
-
0.00
99.00%
0.00
79.06%
0.05
11,217.53%
0.66
1,200.60%
2.13
223.65%
22.75
968.32%
8.36
63.28%
market cap
2.28B
-
2.28B
0%
1.14B
49.81%
7.08B
519.44%
12.57B
77.51%
10.13B
19.36%
2.78B
72.57%
3.03B
9.00%
net current asset value
66.22M
-
208.60M
215.01%
406.54M
94.89%
482.82M
18.76%
972.17M
101.36%
-445.37M
145.81%
-358.21M
19.57%
-280.63M
21.66%
net debt to ebitda
0.42
-
1.02
142.88%
1.69
65.84%
1.60
5.13%
-0.06
103.85%
-2.27
3,586.18%
-1.89
17.08%
-0.34
81.95%
net income per share
-0.65
-
-1.18
80.37%
-2.80
137.74%
-0.75
73.23%
-2.53
237.26%
-3.80
50.36%
-6.41
68.69%
-4.28
33.17%
operating cash flow per share
-0.52
-
-1.02
96.77%
-2.37
132.43%
-0.52
78.09%
-1.07
104.87%
-2.06
93.56%
-3.03
46.80%
-2.90
4.19%
payables turnover
7.01
-
6.33
9.73%
4.06
35.82%
4.37
7.53%
12.61
188.74%
6.99
44.54%
0.89
87.28%
receivables turnover
7.22
-
3.90
46.05%
2.54
34.85%
4.47
75.91%
5.38
20.42%
3.83
28.87%
4.62
20.80%
6.35
37.42%
research and ddevelopement to revenue
0.43
-
0.51
19.25%
0.56
9.10%
0.40
28.06%
0.52
29.84%
0.70
34.78%
0.83
18.04%
0.65
21.70%
return on tangible assets
-0.40
-
-0.25
37.09%
-0.15
41.06%
-0.07
51.02%
-0.11
52.11%
-0.18
60.89%
-0.41
133.27%
-0.27
34.15%
revenue per share
0.36
-
0.70
97.40%
2.98
322.98%
2.37
20.63%
2.94
24.28%
3.69
25.41%
4.40
19.29%
5.04
14.46%
roe
-0.58
-
-0.27
53.42%
-0.18
34.71%
-0.08
51.73%
-0.19
123.18%
-0.60
214.52%
-10.88
1,723.38%
-3.02
72.22%
roic
-0.45
-
-0.25
45.15%
-0.19
22.22%
-0.09
52.19%
-0.12
26.58%
-0.18
57.48%
-0.33
81.53%
-0.34
1.79%
sales general and administrative to revenue
0.39
-
0.74
87.79%
0.40
45.89%
0.29
28.27%
0.67
134.74%
0.55
17.74%
0.36
34.05%
0.28
24.25%
shareholders equity per share
1.13
-
4.36
287.23%
15.89
264.15%
8.81
44.55%
13.32
51.12%
6.37
52.19%
0.59
90.75%
1.42
140.58%
stock based compensation to revenue
0.08
-
0.07
5.67%
0.08
2.65%
0.08
4.63%
0.50
535.52%
0.41
19.36%
0.21
48.03%
0.16
23.59%
tangible asset value
79.70M
-
299.87M
276.26%
517.15M
72.46%
829.29M
60.36%
1.34B
61.11%
627.51M
53.03%
45.16M
92.80%
146.41M
224.19%
tangible book value per share
1.13
-
4.24
276.26%
17.01
301.14%
9.15
46.19%
13.70
49.70%
6.19
54.80%
0.44
92.86%
1.31
195.79%
working capital
88.81M
-
223.31M
151.44%
422.05M
89.00%
524.62M
24.30%
1.82B
247.21%
919.44M
49.52%
998.37M
8.59%
1.14B
14.30%

All numbers in USD (except ratios and percentages)